Have you ever looked in the mirror and thought, “Why does my skin look so tired?” You might be doing everything right: cleansing, moisturizing, exfoliating. Yet, your glow still seems to be missing. The real culprit might be deeper than dryness or dullness. It could be zombie cell those aging skin cells that refuse to retire.

Let’s uncover what these zombie cells really are, how they affect your skin, and how modern peptides are helping us fight them for good.

Think of your skin as a busy city full of hardworking cells. Over time, some of these cells stop functioning properly. But instead of disappearing quietly, they stay behind, causing damage. These are senescent cells, or as scientists call them, zombie cell.

NX210c is emerging as one of the more scientifically grounded preclinical candidates in spinal cord injury research. Spinal cord injury, often referred to as SCI, remains a devastating neurological condition that affects hundreds of thousands of people worldwide every year.

Patients frequently experience permanent motor, sensory, and autonomic deficits below the site of injury. Despite decades of intensive research, pharmacological therapies that reliably restore motor function after SCI remain limited, and most treatment strategies still focus on surgical intervention, acute stabilization, and long-term rehabilitation rather than true neurological repair.

Against this backdrop, NX210c has attracted attention for its multi-dimensional effects in animal models of SCI. Derived from thrombospondin-related biology, NX210c has demonstrated improvements in motor function, tissue preservation, and neuronal signaling in preclinical studies.